Product NDC: | 10139-062 |
Proprietary Name: | Methotrexate |
Non Proprietary Name: | Methotrexate |
Active Ingredient(s): | 25 mg/mL & nbsp; Methotrexate |
Administration Route(s): | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10139-062 |
Labeler Name: | GeneraMedix |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040716 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130506 |
Package NDC: | 10139-062-40 |
Package Description: | 40 mL in 1 VIAL, GLASS (10139-062-40) |
NDC Code | 10139-062-40 |
Proprietary Name | Methotrexate |
Package Description | 40 mL in 1 VIAL, GLASS (10139-062-40) |
Product NDC | 10139-062 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methotrexate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
Start Marketing Date | 20130506 |
Marketing Category Name | ANDA |
Labeler Name | GeneraMedix |
Substance Name | METHOTREXATE |
Strength Number | 25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |